References
- Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama Y. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity; Results in hypertensive subjects. Arch Intern Med 1981; 141: 1589–1593
- Traub Y M. Captopril v aldosterone to plasma renin activity ratio in screening for primary aldosteronism. Arch Intern Med 1982; 142: 2231–2232
- Lyons D F, Kem D C, Brown R D, Hanson C S, Carollo M L. Single oral dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab 1983; 57: 892–896
- Thibonnier M, Sassano P, Joseph A, Plouin P F, Corvol P, Menard J. Diagnostic value of a single dose of captopril in renin- and aldosterone-dependent, surgically curable hypertension. Cardiovascular Rev Rep 1982; 3: 1659–1666
- Kumamoto K, Fukiyama K, Noda Y, Kawasaki T, Takishita S, Omae T. Renin response to upright posture in varying sodium balance in normal young Japanese men. Jpn Heart J 1979; 20: 777–788
- Nakamuta S, Kawasaki T, Uezono K, Omae T. A direct radioimmunoassay determination of plasma aldosterone using 125I - labelled ligand (ALDOCTK-125 Kit). Comparison with method using 3H-labelled ligand (ALDOK Kit). Fukuoka Acta Med 1980; 71: 221–224
- Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C. Effect of angiotensin H and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci 1981; 61: 289s–293s